Handa Pharmaceuticals (ROCO:6620) EV-to-FCF : 6.45 (As of Dec. 14, 2024)

Handa Pharmaceuticals EV-to-FCF Chart

Handa Pharmaceuticals Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
EV-to-FCF		Get a 7-Day Free Trial					-12.12	-8.19	-43.55	-74.41	35.13

Handa Pharmaceuticals Quarterly Data
	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
EV-to-FCF	Get a 7-Day Free Trial															94.99	39.25	35.13	22.05	16.41

Competitive Comparison of Handa Pharmaceuticals's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Handa Pharmaceuticals's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Handa Pharmaceuticals's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Handa Pharmaceuticals's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Handa Pharmaceuticals's EV-to-FCF falls into.

Handa Pharmaceuticals EV-to-FCF Calculation

Handa Pharmaceuticals's EV-to-FCF for today is calculated as:

Handa Pharmaceuticals's current Enterprise Value is NT$4,811.2 Mil.
Handa Pharmaceuticals's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$746.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Handa Pharmaceuticals  (ROCO:6620) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Handa Pharmaceuticals's PE Ratio (TTM) for today is calculated as:

Handa Pharmaceuticals's share price for today is NT$52.00.
Handa Pharmaceuticals's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$3.200.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.

Handa Pharmaceuticals EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Handa Pharmaceuticals's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.

Handa Pharmaceuticals Business Description